The following manuscript was published as a Fast Forward article on May 15, 2012:
Sugiura T, Kageyama S, Andou A, Miyazawa T, Ejima C, Nakayama A, Dohi T, and Eda H, A Novel, Orally Active Alpha 4 Integrin Antagonist, AJM300 Prevents the Development of Experimental Colitis Induced by Adoptive Transfer of IL-10 Deficient CD4+ T Cells in Mice. J Pharmacol Exp Ther jpet.112.193946; doi:10.1124/jpet.112.193946.
It was later found that the chemical identity of AJM300, AJM301, and their formulations were not sufficiently disclosed. The authors are unable, at this time, to provide this information in accordance with the editorial policies of The Journal of Pharmacology and Experimental Therapeutics. As a result, the authors have voluntarily withdrawn this manuscript from publication.
We apologize for any inconvenience this may cause JPET's readers.
- Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics